Literature DB >> 9179302

Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization.

H J George1, P Marchand, K Murphy, B H Wiswall, R Dowling, J Giannaras, G F Hollis, J M Trzaskos, R A Copeland.   

Abstract

Human 92-kDa type IV collagenase/gelatinase (MMP9) has been expressed in insect cells and secreted into the cell medium via a baculovirus expression system. The expression level of the proenzyme from Trichoplusia ni cells was estimated to be > = 300 mg/L of cell medium. The recombinant protein was purified in a single step using heparin-affinity chromatography with an overall yield of ca. 70%. The purified zymogen could be activated in vitro using 4-aminophenylmercuric acetate to yield an active protease. Kinetic analysis of the activated recombinant enzyme demonstrates that this material is comparable to activated MMP9 from natural human sources. The recombinant enzyme provides a useful source of protein for a variety of biochemical and biophysical studies aimed at elucidating the structure and function of human MMP9.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179302     DOI: 10.1006/prep.1997.0725

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Design and synthesis of a Magainin2 fusion protein gene suitable for a mammalian expression system.

Authors:  Baoliang Fan; Ning Li
Journal:  Transgenic Res       Date:  2008-10-16       Impact factor: 2.788

2.  Expression of a New Recombinant Collagenase Protein of Lucilia Sericata in SF9 Insect Cell as a Potential Method for Wound Healing.

Authors:  Hamzeh Alipour; Abbasali Raz; Navid Dinparast Djadid; Sedigheh Zakeri
Journal:  Iran J Biotechnol       Date:  2019-12-01       Impact factor: 1.671

3.  Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B).

Authors:  Fumio Tamura; Rumiko Nakagawa; Teruo Akuta; Shigefumi Okamoto; Shigeyuki Hamada; Hiroshi Maeda; Shigetada Kawabata; Takaaki Akaike
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.